|Articles|August 1, 2003
Targeting Melanoma
Author(s)Caroline Helwick
Chicago - Targeted drug therapy, a rational approach to the treatment of malignant melanoma, offers a number of targeted agents currently in development, according to Scott Saxman, M.D., senior investigator, Cancer Therapy Evaluation Program, National Cancer Institute.
Advertisement
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Dermatology Times
1
Once-Daily Zasocitinib Rivals Injectable Biologics for Skin Clearance, Phase 3 Data Show
2
FDA Accepts Addition of Bemotrizinol as First New Sunscreen Ingredient in 20 Years
3
Oral STAT6 Degrader KT-621 Shows Biologic-Comparable Activity in Atopic Dermatitis
4
Moving Past Dermal Filler Trends to Focus on Healthy Skin Aging
5










